Showing 10 of 120 news

1st March 2022

How the body fights back against cancer

New research from the Quadram Institute and the University of East Anglia reveals how our immune system can be triggered to attack cancer cells. The research, published in the Journal of Clinical Investigation, could help develop new approaches to treating people with leukaemia. The...

View

21st February 2022

Quadram researchers play a vital role in UK’s pandemic response to COVID-19

The Quadram Institute’s key role providing world-leading pathogen genomics expertise as part of the COVID-19 Genomics UK (COG-UK) consortium has been cited in a new report. An independent evaluation by the not-for-profit institute RAND Europe concludes that COG-UK made a significant and valuable contribution...

View
Martin Warren

10th February 2022

Prof Martin Warren appointed Chief Scientific Officer

Professor Martin Warren has been appointed as Chief Scientific Officer (CSO) for the Quadram Institute following an internal competition. The CSO role is pivotal to the development of the Institute’s scientific strategy and the scientific leadership of QIB. Martin will now take up the...

View
Ruminococcus gnavus (green) in the mucus layer (red) of the gut lining (gut cell nuclei are blue). Image by Laura Vaux, Juge Group, the Quadram Institute

10th January 2022

Blood and guts: new link uncovered between the gut microbiome and blood groups

Researchers have discovered that a common member of the human gut microbiome has a specific preference for blood group A antigens. This specificity may give it an advantage when foraging for sugars, allowing it to colonise the gut more easily. The presence of the...

View

6th December 2016

New study unravels critical genes to understand human diseases and support drug discovery

A network analysis of proteins that are most important in responding to environmental signals highlights potential targets for drugs and provides better information on the genetic basis of diseases. Throughout evolutionary history, there have been genetic elements that have duplicated – giving rise to...

View
Houses of Parliament

6th December 2016

Scientists spend a week at Westminster

Two scientists from Norwich Research Park have taken part in a Royal Society scheme to bring the worlds of politics and science closer together. The initiative, run by the Royal Society – the UK’s national academy of science – with support from the Government...

View

29th November 2016

Omnipath sends strong signal

Combining the power of 27 data resources, Omnipath helps researchers see biological signalling pathways with unprecedented accuracy. Developed by researchers in the UK and Germany and published in Nature Methods, OmniPath offers a comprehensive, unified collection of literature-curated signalling pathways based on an...

View

4th November 2016

Diversity in C. botulinum germination

A new study has filled a gap in our knowledge of germination of Clostridium botulinum, one of the most dangerous causes of food poisoning. C. botulinum bacteria produce a highly potent neurotoxin that if present in the body causes botulism, which often leads to...

View
Food Waste

26th October 2016

Landmark alliance launched to support the growth of the UK bioeconomy

The Norwich Research Park Biorefinery Centre has joined a new alliance of similar established R&D centres, called BioPilotsUK. This alliance will seek to position Britain as a global leader in biorefining technology development and bio-based product manufacture – two key elements of the bioeconomy....

View

18th October 2016

Norfolk hospital and science partnership cure patients of debilitating gut infection

A treatment programme for Clostridium difficile (C.diff) is being announced during International Infection Prevention Awareness Week 17-21 October. In the last year, the lives of 20 patients diagnosed with C. diff, a bacterium that infects the gut, have been transformed by the Norfolk and...

View

Showing 10 of 120 news